Ashleigh Tuite
Assistant Professor
University of Toronto Dalla Lana School of Public Health

Senior Epidemiologist
BlueDot Inc.

Postdoctoral Research Fellow (previously held)
Boston Medical Center
Infectious Diseases

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Fisman DN, Amoako A, Simmons A, Tuite AR. Impact of immune evasion, waning and boosting on dynamics of population mixing between a vaccinated majority and unvaccinated minority. PLoS One. 2024; 19(4):e0297093. PMID: 38574059; PMCID: PMC10994315; DOI: 10.1371/journal.pone.0297093;
  2. Peng A, Bosco S, Simmons AE, Tuite AR, Fisman DN. Impact of community mask mandates on SARS-CoV-2 transmission in Ontario after adjustment for differential testing by age and sex. PNAS Nexus. 2024 Feb; 3(2):pgae065. PMID: 38463611; PMCID: PMC10923507; DOI: 10.1093/pnasnexus/pgae065;
  3. Yan P, Mullah MAS, Tuite A. A proportional incidence rate model for aggregated data to study the vaccine effectiveness against COVID-19 hospital and ICU admissions. Biometrics. 2023 Dec; 79(4):3954-3967. PMID: 37561066
  4. Lin YJ, Evans DH, Robbins NF, Orjuela G, Abe KT, Rathod B, Colwill K, Gingras AC, Tuite A, Yi QL, O'Brien SF, Drews SJ. Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021. Microbiol Spectr. 2023 Aug 17; 11(4):e0525622. PMID: 37289096; PMCID: PMC10434250; DOI: 10.1128/spectrum.05256-22;
  5. Tuite AR, Ng V, Ximenes R, Diener A, Rafferty E, Ogden NH, Tunis M. Quantifying the economic gains associated with COVID-19 vaccination in the Canadian population: A cost-benefit analysis. Can Commun Dis Rep. 2023 Jun 01; 49(6):263-273. PMID: 38440772; PMCID: PMC10911688; DOI: 10.14745/ccdr.v49i06a03;
  6. Peng A, Simmons A, Amoako A, Tuite A, Fisman D. Relative pandemic severity in Canada and four peer nations during the SARS-CoV-2 pandemic. Can Commun Dis Rep. 2023 May 01; 49(5):197-205. PMID: 38419909; PMCID: PMC10901147; DOI: 10.14745/ccdr.v49i05a05;
  7. Simmons AE, Amoako A, Grima AA, Murison KR, Buchan SA, Fisman DN, Tuite AR. Vaccine effectiveness against hospitalization among adolescent and pediatric SARS-CoV-2 cases between May 2021 and January 2022 in Ontario, Canada: A retrospective cohort study. PLoS One. 2023; 18(3):e0283715. PMID: 37000810; PMCID: PMC10065234; DOI: 10.1371/journal.pone.0283715;
  8. Murison KR, Grima AA, Simmons AE, Tuite AR, Fisman DN. Severity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Pregnancy in Ontario: A Matched Cohort Analysis. Clin Infect Dis. 2023 Feb 08; 76(3):e200-e206. PMID: 35792660; PMCID: PMC9907552; DOI: 10.1093/cid/ciac544;
  9. Grima AA, Murison KR, Simmons AE, Tuite AR, Fisman DN. Relative Virulence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Vaccinated and Unvaccinated Individuals Hospitalized With SARS-CoV-2. Clin Infect Dis. 2023 Feb 08; 76(3):e409-e415. PMID: 35616115; PMCID: PMC9278128; DOI: 10.1093/cid/ciac412;
  10. Obress L, Berke O, Fisman DN, Raju S, Tuite AR, Varia M, Greer AL. Estimating the test-adjusted incidence of Chlamydia trachomatis infections identified through Public Health Ontario Laboratories in Peel region, Ontario, 2010-2018: a population-based study. CMAJ Open. 2023; 11(1):E62-E69. PMID: 36693657; PMCID: PMC9876583; DOI: 10.9778/cmajo.20210236;
Showing 10 of 118 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 118 publications over 20 distinct years, with a maximum of 24 publications in 2020

Contact for Mentoring:

Tuite's Networks
Click the "See All" links for more information and interactive visualizations
Similar People